A Clinical Decision Support System for Remote Monitoring of Cardiovascular Disease Patients: A Clinical Study Protocol

Abstract

IntroductionCardiovascular diseases (CVD) are the leading cause of death globally, taking an estimated 17. 9 million lives each year. Cardiac rehabilitation is shown to reduce mortality and hospital readmissions, while improving physical fitness and quality of life. Despite the recommendations and proven benefits, acceptance and adherence remain low. Mobile health (mHealth) solutions may contribute to more personalized and tailored patient recommendations according to their specific needs. This study protocol aims to assess the effectiveness of a user-friendly, comprehensive Clinical Decision Support System (CDSS) for remote patient monitoring of CVD patients, primarily on the reduction of recurrent cardiovascular events.Methods and AnalysisThe study will follow a multicenter randomized controlled design involving two cardiology units in the Center Region of Portugal. Prospective CVD patients will be approached by the healthcare staff at each unit and checked for eligibility according to the predefined inclusion/exclusion criteria. The CDSS will suggest a monitoring plan for the patient, will advise the mHealth tools (apps and wearables) adapted to patient needs, and will collect data. The clinical study will start in January 2023.DiscussionThe success of the mHeart.4U intervention will be a step toward the use of technological interfaces as an integrating part of CR programs.Ethics and DisseminationThe study will undergo ethical revision by the Ethics Board of the two hospital units where the study will unfold. The study was registered in ClinicalTrials.gov on 18th January 2022 with the number NCT05196802. The study findings will be published in international peer-reviewed scientific journals and encounters and in a user-friendly manner to the society.

Some Things Change, Some Things Stay the Same: Trends in Canadian Education in Paediatric Cardiology and the Cardiac Sciences

“…Teaching learners to use these systems, and to recognize the systems' limitations, may become a part of future educational offerings. Work is also beginning to assess the ability of cardiacspecific systems to help reduce negative cardiovascular outcomes through patient monitoring 19,20 Some are advocating for the inclusion of these tools even within examinations, as they more accurately reflect the tools available to practicing clinicians. ECG's already use complex artificial intelligence algorithms to suggest an interpretation.…”

Implementation of the Management of Anticoagulation in the Periprocedural Period App into an Electronic Health Record: A Cost-Effectiveness Analysis

“…A common use case of this paradigm is chronic conditions with rapidly changing treatment guidelines, such as cardiovascular diseases, where the use of mobile apps and wearable devices has been increasingly gaining interest from both academic centers and industrial stakeholders worldwide. 2 This is even more important when considering the potential cost-effectiveness of such implementations, given the low cost of owning a modern mobile device and the easily accessible online health-related resources. In a recent systematic review of the cost-effectiveness of digital health interventions for the management of cardiovascular diseases (including short message services, telephone support, mobile applications, video conferencing systems, digital transmission of physiologic data, and wearable medical devices), the use of digital health interventions was deemed cost-effective.…”